Does ALECTINIB Cause Therapy non-responder? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Therapy non-responder have been filed in association with ALECTINIB (ALECENSA). This represents 0.2% of all adverse event reports for ALECTINIB.
15
Reports of Therapy non-responder with ALECTINIB
0.2%
of all ALECTINIB reports
3
Deaths
1
Hospitalizations
How Dangerous Is Therapy non-responder From ALECTINIB?
Of the 15 reports, 3 (20.0%) resulted in death, 1 (6.7%) required hospitalization.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALECTINIB. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does ALECTINIB Cause?
Death (702)
Fatigue (618)
Constipation (525)
Off label use (495)
No adverse event (488)
Disease progression (366)
Rash (312)
Dyspnoea (296)
Drug ineffective (269)
Myalgia (268)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which ALECTINIB Alternatives Have Lower Therapy non-responder Risk?
ALECTINIB vs ALEMTUZUMAB
ALECTINIB vs ALENDRONATE
ALECTINIB vs ALENDRONATE\CHOLECALCIFEROL
ALECTINIB vs ALENDRONIC ACID
ALECTINIB vs ALEVE